Enhanced Th17 phenotype in individuals with generalized anxiety disorder

Journal of Neuroimmunology

Volumn 229, Issue 1-2, 2010, Pages 212-218

  Vieira, Morgana M M ^a   Ferreira, Thais B ^a   Pacheco, Paulo A F ^a   Barros, Priscila O ^a   Almeida, Carla R M ^a   Araújo Lima, Carlos Fernando ^a   Silva Filho, Renato G ^a   Hygino, Joana ^a   Andrade, Regis M ^a   Linhares, Ulisses C ^b   Andrade, Arnaldo F B ^b   Bento, Cleonice A M ^a  

^a FEDERAL UNIVERSITY OF THE STATE OF RIO DE JANEIRO   (Brazil)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Generalized anxiety disorder; Th1; Th17; Th2; Tr 1

Indexed keywords

INTERLEUKIN 17; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; CELL TYPE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENERALIZED ANXIETY DISORDER; HUMAN; HUMORAL IMMUNITY; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MALE; NEUROPATHOLOGY; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL;

ADOLESCENT; ADULT; ANXIETY DISORDERS; CELL COUNT; CYTOKINES; DEXAMETHASONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOCORTICOIDS; HUMANS; INTERLEUKIN-7; LYMPHOCYTE ACTIVATION; MALE; PHENOTYPE; STATISTICS, NONPARAMETRIC; TETRAZOLIUM SALTS; TH17 CELLS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 78650192140     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.07.018     Document Type: Article

References (105)

1. Affleck G., Urrows S., Tennen H., Higgins P., Pav D., Aloisi R. A dual pathway model of daily stressor effects on rheumatoid arthritis. Ann. Behav. Med. 1997, 19:161-170.
2. Agarwal S.K., Marshall G.D. Glucocorticoid-induced type 1/type 2 cytokine alterations in humans: a model for stress-related immune dysfunction. J. Interferon Cytokine Res. 1998, 18:1059-1068.
3. Akkoc T., de Koning P.J., Rückert B., Barlan I., Akdis M., Akdis C.A. Increased activation-induced cell death of high IFN-gamma-producing T(H)1 cells as a mechanism of T(H)2 predominance in atopic diseases. J. Allergy Clin. Immunol. 2008, 121(3):652-658.
4. Altemus M., Cloitre M., Dhabhar F.S. Enhanced cellular response in women with PTSD related to childhood abuse. Am. J. Psychiatry 2003, 160:1705-1707.
5. Andoh A., Takaya H., Makino J., Sato H., Bamba S., Araki Y., Hata K., Shimada M., Okuno T., Fujiyama Y., Bamba T. Cooperation of interleukin-17 and interferon-gamma on chemokine secretion in human fetal intestinal epithelial cells. Clin. Exp. Immunol. 2001, 125:56-63.
6. Arborelius L., Owens M.J., Plotsky P.M., Nemeroff C.B. The role of corticotropin-releasing factor in depression and anxiety disorders. J. Endocrinol. 1999, 160:1-12.
7. Arican O., Aral M., Sasmaz S., Ciragil P. Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediat. Inflamm. 2005, 2005:273-279.
8. Arranz L., Guayerbas N., De la Fuente M. Impairment of several immune functions in anxious women. J. Psychosom. Res. 2007, 62(1):1-8.
9. Ashwell J.D., Lu F.W., Vacchio M.S. Glucocorticoids in T cell development and function. Annu. Rev. Immunol. 2000, 18:309.
10. Aviles H., Johnson M.T., Monroy F.P. Effects of cold stress on spleen cell proliferation and cytokine production during chronic Toxoplasma gondii infection. Neuroimmunomodulation 2004, 11(2):93-102.
11. Belkaid Y. Regulatory T cells and infection: a dangerous necessity. Nat. Rev. Immunol. 2007, 7:875-888.
12. Ben-Eliyahu S. The promotion of tumor metastasis by surgery and stress: immunological basis and implications for psychoneuroimmunology. Brain Behav. Immun. 2003, 17(Suppl. 1):S27-S36.
13. Bonaccorso S., Puzella A., Marino V., Pasquini M., Biondi M., Artini M., Almerighi C., Levrero M., Egyed B., Bosmans E., Meltzer H.Y., Maes M. Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms. Psychiatry Res. 2001, 105(1-2):45-55.
14. Boscarino J.A. Posttraumatic stress disorder and physical illness: results from clinical and epidemiologic studies. Ann. NY Acad. Sci. 2004, 1032:141-153.
15. Boscarino J.A., Chang J. Higher abnormal leukocyte and lymphocyte counts 20years after exposure to severe stress: research and clinical implications. Psychosom. Med. 1999, 61:378-386.
16. Burchill M.A., Yang J., Vang K.B., Farrar M.A. Interleukin-2 receptor signaling in regulatory T cell development and homeostasis. Immunol. Lett. 2007, 114:1-8.
17. Burns V.E., Drayson M., Ring C., Carroll D. Perceived stress and psychological well-being are associated with antibody status after meningitis C conjugate vaccination. Psychosom. Med. 2002, 64(6):963-970.
18. Butts C.L., Sternberg E.M. Neuroendocrine factors alter host defense by modulating immune function. Cell. Immunol. 2008, 252(1-2):7-15.
19. Chabaud M., Fossiez F., Taupin J.L., Miossec P. Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines. J. Immunol. 1998, 161:409-414.
20. Cohen I.R., Schwartz M. Autoimmune maintenance and neuroprotection of the central nervous system. J. Neuroimmunol. 1999, 100:111-114.
21. Cohen F., Kemeny M.E., Kearney K.A., Zegans L.S., Neuhaus J.M., Conant M.A. Persistent stress as a predictor of genital herpes recurrence. Arch. Intern. Med. 1999, 159:2430-2436.
22. Costantino C.M., Baecher-Allan C.M., Hafler D.A. Human regulatory T cells and autoimmunity. Eur. J. Immunol. 2008, 38:921-924.
23. Crozat K., Vivier E., Dalod M. Crosstalk between components of the innate immune system: promoting anti-microbial defenses and avoiding immunopathologies. Immunol. Rev. 2009, 227:129-149.
24. Dai H., Daí Z. The role of tryptophan catabolism in acquisition and effector function of memory T cells. Curr. Opin. Organ Transplant. 2008, 13:31-35.
25. Dantzer R. Cytokine-induced sickness behavior: where do we stand?. Brain Behav. Immun. 2001, 15:7-24.
26. Davidson T.S., DiPaolo R.J., Andersson J., Shevach E.M. Cutting edge: IL-2 is essential for TGF-beta-mediated induction of Foxp3+ T regulatory cells. J. Immunol. 2007, 178:4022-4026.
27. De Bosscher K., Vanden Berghe W., Vermeulen L., Plaisance S., Boone E., Haegeman G. Glucocorticoids repress NF-kappaBdriven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell. Proc. Natl Acad. Sci. USA 2000, 97(8):3919-3924.
28. De Kloet C.S., VermettenGeuze E., Kavelaars E., Heijnen A., Westenberg C.J. Assessment of HPA-axis function in posttraumatic stress disorder: pharmacological and non-pharmacological challenge tests, a review. J. Psychiatry Res. 2006, 40(6):550-567.
29. De Kloet C.S., Vermetten E., Bikker A., Meulman E., Geuze E., Kavelaars A., Westenberg H.G., Heijnen C.J. Leukocyte glucocorticoid receptor expression and immuneregulation in veterans with and without post-traumatic stress disorder. Mol. Psychiatry 2007, 12:443-453.
30. Ekkens M.J., Liu Z., Liu Q., Whitmire J., Xiao S., Foster A., Pesce J., VanNoy J., Sharpe A.H., Urban J.F., Gause W.C. The role of OX40 ligand interactions in the development of the Th2 response to the gastrointestinal nematode parasite Heligmosomoides polygyrus. J. Immunol. 2003, 170(1):384-393.
31. Fortune D.G., Richards H.L., Griffiths C.E.M., Main C.J. Psychologic factors in psoriasis: consequences, mechanisms, and interventions. Dermatol. Clin. 2005, 4:681-694.
32. Franchimont D., Galon J., Gadina M., Visconti R., Zhou Y., Aringer M., Frucht D.M., Chrousos G.P., O'shea J.J. Inhibition of Th1 immune response by glucocorticoids: dexamethasone selectively inhibits IL-12-induced Stat4 phosphorylation in T lymphocytes. J. Immunol. 2000, 164:1768-1774.
33. Gill J.M., Vythilingam M., Page G. Low cortisol, high DHEA, and high levels of TNF-a and IL-6 in women with PTSD. J. Trauma. Stress 2008, 21(6):530-539.
34. Gill J.M., Saligan L., Woods S., Page G. PTSD is associated with an excess of inflammatory immune activities. Perspect. Psychiatr. Care 2009, 45(4):262-277.
35. Glaser R., Kiecolt-Glaser J.K., Bonneau R.H., Malarkey W., Kennedy S., Hughes J. Stress-induced modulation of the immune response to recombinant hepatitis B vaccine. Psychosom. Med. 1992, 54(1):22-29.
36. Glaser R., Sheridan J., Malarkey W.B., MacCallum R.C., Kiecolt-Glaser J.K. Chronic stress modulates the immune response to a pneumococcal pneumonia vaccine. Psychosom. Med. 2000, 62(6):804-807.
37. Godbout J.P., Glaser R. Stress-induced immune dysregulation: implications for wound healing, infectious disease and cancer. J. Neuroimmune Pharmacol. 2006, 1:421-427.
38. Goehler L.E., Lyte M., Gaykema R.P.A. Infection-induced viscerosensory signals from the gut enhance anxiety: implications for psychoneuroimmunology. Brain Behav. Immun. 2007, 21:721-726.
39. Gotovac K., Sabioncello A., Rabatic S., Berki T., Dekaris D. Flow cytometric determination of glucocorticoid receptor (GCR) expression in lymphocyte subpopulations: lower quantity of GCR in individuals with post-traumatic stress disorder (PTSD). Clin. Exp. Immunol. 2003, 131:335-339.
40. Gutcher I., Becher B. APC-derived cytokines and T cell polarization in autoimmune inflammation. J. Clin. Invest. 2007, 117:1119-1125.
41. Hamilton M. The assessment of anxiety states by rating. Br. J. Med. Psychol. 1959, 32:50-55.
42. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 2000, 23:477-501.
43. Horwitz D.A., Zheng S.G., Wang J., Gray J.D. Critical role of IL-2 and TGF-beta in generation, function and stabilization of Foxp3+CD4+ Treg. Eur. J. Immunol. 2008, 38:912-915.
44. Jabaaij L., van Hattum J., Vingerhoets J.J., Oostveen F.G., Duivenvoorden H.J., Ballieux R.E. Modulation of immune response to rDNA hepatitis B vaccination by psychological stress. J. Psychosom. Res. 1996, 41(2):129-137.
45. Jovanovic D.V., Di Battista J.A., Martel-Pelletier J., Jolicoeur F.C., He Y., Zhang M., Mineau F., Pelletier J.P. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J. Immunol. 1998, 160:3513-3521.
46. Jovanovic D.V., Martel-Pelletier J., Di Battista J.A., Mineau F., Jolicoeur F.C., Benderdour M., Pelletier J.P. Stimulation of 92-kd gelatinase (matrix metalloproteinase 9) production by interleukin-17 in humanmonocyte/macrophages: a possible role in rheumatoid arthritis. Arthritis Rheum. 2000, 43:1134-1144.
47. Jovanovic D.V., Di Battista J.A., Martel-Pelletier J., Reboul P., He Y., Jolicoeur F.C., Pelletier J.P. Modulation of TIMP-1 synthesis by antiinflammatory cytokines and prostaglandin E2 in interleukin 17 stimulated human monocytes/macrophages. J. Rheumatol. 2001, 28:712-718.
48. Kang D., Davidson R.J., Coe C.L., Wheeler R.E., Tomarken A.J., Erschler W.B. Frontal brain asymmetry and immune function. Behav. Neurosci. 1991, 105:860-869.
49. Katz Y., Nadiv O., Beer Y. Interleukin-17 enhances tumor necrosis factor alpha-induced synthesis of interleukins 1, 6, and 8 in skin and synovial fibroblasts: a possible role as a 'fine-tuning cytokine' in inflammation processes. Arthritis Rheum. 2001, 44:2176-2184.
50. Khouzam H.R. Anxiety disorders: guidelines for effective primary care. Part 1: diagnosis. Consultant 2009, 49(3).
51. Kiecolt-Glaser J.K., Glaser R., Gravenstein S., Malarkey W.B., Sheridan J. Chronic stress alters the immune response to influenza virus vaccine in older adults. Proc. Natl Acad. Sci. USA 1996, 93(7):3043-3047.
52. Kimerling R. An investigation of sex differences in nonpsychiatric morbidity associated with posttraumatic stress disorder. J. Am. Med. Womens Assoc. 2004, 59:43-47.
53. Kitani A., Fuss I., Nakamura K., Kumaki F., Usui T., Strober W. Transforming growth factor (TGF)-beta1-producing regulatory T cells induce Smad-mediated interleukin 10 secretion that facilitates coordinated immunoregulatory activity and amelioration of TGF-beta1-mediated fibrosis. J. Exp. Med. 2003, 198:1179-1188.
54. Koh K.B., Lee Y. Reduced anxiety level by therapeutic interventions and cell-mediated immunity in panic disorder patients. Psychother. Psychosom. 2004, 73(5):286-292.
55. Kohn P.M., Kantor L., DeCicco T.L., Beck A.T. The Beck Anxiety Inventory-Trait (BAIT): a measure of dispositional anxiety not contaminated by dispositional depression. J. Person. Assess. 2008, 90:499-506.
56. Kurasawa K., Hirose K., Sano H., Endo H., Shinkai H., Nawata Y., Takabayashi K., Iwamoto I. Increased interleukin-17 production in patients with systemic sclerosis. Arthritis Rheum. 2000, 43:2455-2463.
57. LeGrand A., Fermor B., Fink C., Pisetsky D.S., Weinberg J.B., Vail T.P., Guilak F. Interleukin-1, tumor necrosis factor alpha, and interleukin-17 synergistically up-regulate nitric oxide and prostaglandin E2 production in explants of human osteoarthritic knee menisci. Arthritis Rheum. 2001, 44:2078-2083.
58. Lemieux A.M., Coe C.L. Abuse-related post-traumatic stress disorder: evidence of chronic neuroendocrine activation in women. Psychosom. Med. 1995, 57:105-115.
59. Lemieux A., Coe C.L., Carnes M. Symptom severity predicts degree of T cell activation in adult women following childhood maltreatment. Brain Behav. Immun. 2008, 22(6):994-1003.
60. Li M.O., Flavell R.A. Contextual regulation of inflammation: a duet by transforming growth factor-b and interleukin-10. Immunity 2008, 8:468-476.
61. Lubberts E., Joosten L.A., van de Loo F.A., van den Gersselaar L.A., van den Berg W.B. Reduction of interleukin-17-induced inhibition of chondrocyte proteoglycan synthesis in intact murine articular cartilage by interleukin-4. Arthritis Rheum. 2000, 43:1300-1306.
62. Makani S.S., Jen K.Y., Finn P.W. New costimulatory families: signaling lymphocytic activation molecule in adaptive allergic responses. Curr. Mol. Med. 2008, 8:359-364.
63. Matsuzaki G., Umemura M. IL-17 as an effetor molecule of innate and acquired immunity against infections. Microbiol. Immunol. 2007, 51:1139-1147.
64. Matusevicius D., Kivisäkk P., He B., Kostulas N., Ozenci V., Fredrikson S., Link H. Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult. Scler. 1999, 5:101-104.
65. Maynard C.L., Harrington L.E., Janowski K.M., Oliver J.R., Zindl C.L., Rudensky A.Y., Weaver C.T. Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3-precursor cells in the absence of interleukin 10. Nat. Immunol. 2007, 8:931-941.
66. McGeachy M.J., Stephens L.A., Anderton S.M. Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory T cells within the central nervous system. J. Immunol. 2005, 175:3025-3032.
67. Miller G.E., Cohen S., Pressman S., Barkin A., Rabin B.S., Treanor J.J. Psychological stress and antibody response to influenza vaccination: when is the critical period for stress, and how does it get inside the body?. Psychosom. Med. 2004, 66(2):215-223.
68. Miossec P. IL-17 and Th17 cells in human inflammatory diseases. Microb. Infect. 2009, 11:625-630.
69. Morag M., Morag A., Reichenberg A., Lerer B., Yirmiya R. Psychological variables as predictors of rubella antibody titers and fatigue-a prospective, double blind study. J. Psychiatr. Res. 1999, 33(5):389-395.
70. Muller N., Schwarz M.J. Immunology in anxiety and depression. Handbook of Depression and Anxiety 2002, 267-288. Marcel Dekker, New York. S. Kasper, J.A. den Boer, J.M.A. Sitsen (Eds.).
71. Newcomb D.C., Zhou W., Moore M.L., Goleniewska K., Hershey G.K., Kolls J.K., Peebles R.S. A functional IL-13 receptor is expressed on polarized murine CD4+ Th17 cells and IL-13 signaling attenuates Th17 cytokine production. J. Immunol. 2009, 182:5317-5321.
72. O'Connor J.C., André C., Wang Y., Lawson M.A., Szegedi S.S., Lestage J., Castanon N., Kelley K.W., Dantzer R. Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2, 3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin. J. Neurosci. 2009, 29:4200-4209.
73. O'Donovan A., Hughes B.M., Slavich G.M., Lynch L., Cronin M.T., O'Farrelly C., Malone K.M. Clinical anxiety, cortisol and interleukin-6: Evidence for specificity in emotion-biology relationships. Brain Behav. Immun. 2010, 18.
74. Osorio F., LeibundGut-Landmann S., Lochner M., Lahl K., Sparwasser T., Eberl G., Reis e Sousa C. DC activated via dectin-1 convert Treg into IL-17 producers. Eur. J. Immunol. 2008, 38:3274-3281.
75. Pace T.W., Hu F., Miller A.H. Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav. Immun. 2007, 21:9-19.
76. Padgett D.A., Glaser R. How stress influences the immune response. Trends Immunol. 2003, 24(8):444-448.
77. Pahl H.L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999, 18:6853-6866.
78. Pasare C., Medzhitov R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 2003, 299:1033-1036.
79. Poliak S., Mor F., Conlon P., Wong T., Ling N., Rivier J., Vale W., Steinman L. Stress and autoimmunity: the neuropeptides corticotrophin releasing factor and urocortin suppress encephalomyelitis via effects on both the hypothalamic-pituitary-adrenal axis the immune system. J. Immunol. 1997, 158:5751-5756.
80. Roehm N.W., Rodgers G.H., Hatfield S.M., Glasebrook A.L. An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt MTT. J. Immunol. Meth. 1991, 142:257-265.
81. Romagnani S. The Th1/Th2 paradigm. Immunol. Today 1997, 18:263-266.
82. Sareen J., Cox B.J., Clara I., Asmundson G.J. The relationship between anxiety disorders and physical disorders in the U.S. National Comorbidity Survey. Depress. Anxiety 2005, 21:193-202.
83. Schneiderman N., Ironson G., Siegel S.D. Stress and health: psychological, behavioral, and biological determinants. Annu. Rev. Clin. Psychol. 2005, 1:607-628.
84. Shevach E.M. Mechanisms of Foxp3+ T regulatory cell-mediated suppression. Immunity 2009, 30:636-645.
85. Sommershof A., Aichinger H., Engler H., Adenauer H., Catani C., Boneberg E.M., Elbert T., Groettrup M., Kolassa I.T. Substantial reduction of naïve and regulatory T cells following traumatic stress. Brain Behav. Immun. 2009, 23(8):1117-1124.
86. Spitzer R.L., Williams J.B., Gibbon M., First M.B. The structured clinical interview for DSM-III-R (SCID). I: history, rationale, and description. Arch. Gen. Psychiatry 1992, 49(8):624-629.
87. Sternberg E.M. Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nature Rev. Immunol. 2006, 6:318-328.
88. Steinman L. Elaborate interactions between the immune and nervous systems. Nat. Immunol. 2004, 5(6):575-581.
89. Strauman T.J., Lemieux A.M., Coe C.L. Self-discrepancies and natural killer cell activity: immunological consequences of negative self-evaluation. J. Pers. Soc. Psychol. 1993, 64:1042-1052.
90. Strauman T.J., Woods T.E., Schneider K.L., Kwapil L., Coe C.L. Self-regulatory cognition and immune reactivity: idiographic success and failure feedback effects on the natural killer cell. Brain Behav. Immun. 2004, 18:544-554.
91. Sutherland A.G., Alexander D.A., Hutchison J.D. Disturbance of pro-inflammatory cytokines in post-traumatic psychopathology. Cytokine 2003, 24:219-225.
92. Sutmuller R.P., Morgan M.E., Netea M.G., Grauer O., Adema G.J. Toll-like receptors on regulatory T cells: expanding immuneregulation. Trends Immunol. 2006, 27:387-393.
93. Takkouche B., Regueira C., Gestal-Otero J.J. A cohort study of stress and the common cold. Epidemiology 2001, 12:345-349.
94. Toh M.C., Kawashima M., Zrioual S., Hot A., Miossec P. IL-17 inhibits human Th17 differentiation through IL-12 beta 2 downregulation. Cytokine 2009, 48:226-230.
95. Tuluc F., Lai J.P., Kilpatrick L.E., Evans D.L., Douglas S.D. Eurokinin 1 receptor isoforms and the control of innate immunity. Trends Immunol. 2009, 30(6):271-276.
96. van de Veerdonk F.L., Gresnigt M.S., Kullberg B.J., van der Meer J.W., Joosten L.A., Netea M.G. Th17 responses and host defense against microorganisms: an overview. BMB Rep. 2009, 42:776-787.
97. Vedhara K., Cox N.K., Wilcock G.K., Perks P., Hunt M., Anderson S., Lightman S.L., Shanks N.M. Chronic stress in elderly carers of dementia patients and antibody response to influenza vaccination. Lancet 1999, 353(9153):627-631.
98. Vignali D.A., Collison L.W., Workman C.J. How regulatory T cells work. Nat. Rev. Immunol. 2008, 8:523-532.
99. von Känel R., Hepp U., Kraemer B., Traber R., Keel M., Mica L., Schnyder U. Evidence for low-grade systemic proinflammatory activity in individuals with posttraumatic stress disorder. J. Psychiatr. Res. 2007, 41:744-752.
100. von Känel R., Begré S., Abbas C.C., Saner H., Gander M.L., Schmid J.P. Inflammatory biomarkers in patients with posttraumatic stress disorder caused by myocardial infarction and the role of depressive symptoms. Neuroimmunomodulation 2010, 17:39-46.
101. Wessa M., Rohleder N. Endocrine and inflammatory alterations in posttraumatic stress disorder. Expert Rev. Endocrinol. Metab. 2007, 2:91-122.
102. Wilson S., van der Kolk B., Burbridge J., Fisler R., Kradin R. Phenotype of blood lymphocytes in PTSD suggests chronic immune activation. Psychosomatics 1999, 40:222-225.
103. Wright R.J., Finn P., Contreras J.P., Cohen S., Wright R.O., Staudenmayer, Wand M., Perkins D., Weiss S.T., Gold D.R. Chronic caregiver stress and IgE expression, allergen-induced proliferation, and cytokine profiles in a birth cohort predisposed to atopy. J. Allergy Clin. Immunol. 2004, 113:1051-1057.
104. Yang X.O., Nurieva R., Martinez G.J., Kang H.S., Chung Y., Pappu B.P., Shah B., Chang S.H., Schluns K.S., Watowich S.S., Feng X.H., Jetten A.M., Dong C. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 2008, 29:44-56.
105. Zhou F.L., Zhang W.G., Wei Y.C., Xu K.L., Hui L.Y., Wang X.S., Li M.Z. Impact of comorbid anxiety and depression on quality of life and cellular immunity changes in patients with digestive tract cancers. World J. Gastroenterol. 2005, 11(15):2313-2318.